Supernus Pharmaceuticals
SUPN
#5346
Rank
HK$12.63 B
Marketcap
HK$216.89
Share price
5.73%
Change (1 day)
-38.57%
Change (1 year)

Supernus Pharmaceuticals (SUPN) - Total liabilities

Total liabilities on the balance sheet as of June 2026 : HK$3.11 Billion

According to Supernus Pharmaceuticals 's latest financial reports the company's total liabilities are HK$3.11 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Supernus Pharmaceuticals - Total liabilities on balance sheet (from 2009 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31HK$2.78 B-56.39%
2022-12-31HK$6.37 B-6.34%
2021-12-31HK$6.80 B15.7%
2020-12-31HK$5.88 B33.79%
2019-12-31HK$4.39 B7.05%
2018-12-31HK$4.10 B235.06%
2017-12-31HK$1.22 B34.25%
2016-12-31HK$0.91 B17.15%
2015-12-31HK$0.77 B4.64%
2014-12-31HK$0.74 B23.96%
2013-12-31HK$0.60 B112.97%
2012-12-31HK$0.28 B-17.93%
2011-12-31HK$0.34 B-51.6%
2010-12-31HK$0.71 B6.52%
2009-12-31HK$0.66 B2.94%
2008-12-31HK$0.64 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
HK$908.78 B 29,101.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
HK$452.66 B 14,445.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$845.31 B 27,061.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$512.57 B 16,370.35%๐Ÿ‡บ๐Ÿ‡ธ USA
United Therapeutics
UTHR
HK$6.42 B 106.56%๐Ÿ‡บ๐Ÿ‡ธ USA